z-logo
Premium
ALDOSTERONE‐PRODUCING ADENOMAS RESPONSIVE TO ANGIOTENSIN POSE PROBLEMS IN DIAGNOSIS
Author(s) -
Gordon R. D.,
Hamlet S. M.,
Tunny T. J.,
Klemm S. A.
Publication year - 1987
Publication title -
clinical and experimental pharmacology and physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 103
eISSN - 1440-1681
pISSN - 0305-1870
DOI - 10.1111/j.1440-1681.1987.tb00371.x
Subject(s) - angiotensin iii , aldosterone , angiotensin ii , renin–angiotensin system , endocrinology , medicine , primary aldosteronism , fludrocortisone , hyperaldosteronism , angiotensin ii receptor type 1 , angiotensin receptor , hyperplasia , adrenal gland , adrenal adenoma , adenoma , hydrocortisone , blood pressure
SUMMARY 1. A subgroup of patients with aldosterone‐producing adenoma (APA) have been identified who lack many of the biochemical features regarded as characteristic of APA and used to distinguish APA from bilateral adrenal hyperplasia. 2. In these patients, aldosterone is responsive to infused angiotensin II (angiotensin‐responsive APA), which explains their uncharacteristic responses to upright posture, saline infusion and fludrocortisone acetate administration. 3. The angiotensin‐responsiveness of these patients may derive from the contra‐lateral adrenal gland, since renin levels are less completely suppressed in angiotensin‐responsive APA than in angiotensin‐unresponsive APA. 4. However, while the excretion of 18‐oxo‐cortisol was consistently increased in angiotensin‐unresponsive APA, it was normal in angiotensin‐responsive APA, consistent with biochemical and biosynthetic distinctiveness residing in the tumours. 5. Angiotensin‐responsive APA should always be considered as an alternative diagnosis to bilateral hyperplasia causing primary aldosteronism.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom